COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants

Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.

Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.

virus variant
What Scientists Know About the B.1.617 Coronavirus Variant
What Scientists Know About the B.1.617 Coronavirus Variant
Shawna Williams | May 3, 2021
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.